今年国家将为适龄女生提供HPV疫苗接种，纳入国家免疫规划

Group 1 - The Chinese government will introduce HPV vaccination services for eligible girls and include the HPV vaccine in the national immunization program, aiming to protect women's health [1][2] - China has a high burden of cervical cancer, with approximately 150,000 new cases and 56,000 deaths reported in 2022, accounting for 23% of global cases, and the incidence rate is rising, particularly among younger populations [1] - The inclusion of the HPV vaccine in the national immunization program is expected to maximize public health benefits and provide free vaccination opportunities for the most vulnerable populations [1][2] Group 2 - Experts have been advocating for the HPV vaccine to be included in the national immunization program to ensure equitable access to vaccination services across different socio-economic conditions [2] - The announcement marks a significant update to China's national immunization program, which has not expanded its vaccine offerings since 2007, and represents the first inclusion of a vaccine targeting a non-communicable disease [2] - This initiative is seen as an important exploration for the public health system, potentially paving the way for a comprehensive immunization program that spans the entire lifecycle [2]